“…More recently, whole‐exome sequencing (WES) studies have confirmed the role of variants in known NSCLP genes ( IRF6 , CDH1 , CRISPLD2 , FGFR2 , and PAX7) and identified novel candidate genes ( CTNND1 , PLEKHA7 , PLEKHA5 , and ESRP2 ) (Bureau et al, ; Cox et al, ; Pengelly et al, ). Furthermore, there is increasing evidence supporting an additive role for gene–gene interactions in NSCLP, with modifier phenotypic effects (Carlson et al, ; Chiquet et al, ; Li et al, ; D. Liu et al, ; Velazquez‐Aragon et al, ; Zhou et al, ).…”